Doris Vandeputte

Doris Vandeputte is a researcher in Clinical Sciences at Vrije Universiteit Brussel with an h-index of 13 and 4782 citations. Her research spans 21 publications from 2015-2024, demonstrating sustained scholarly activity in microbiome science.

Her primary research interests include:

• Microbiota (100% research focus)
• Gastrointestinal Microbiome (99% research focus)
• Bacteroides (49% research focus)
• Firmicutes (37% research focus)
• Microbial Genome (25% research focus)

Dr. Vandeputte's work examines the connections between gut microbial communities and human health conditions including ulcerative colitis, type 2 diabetes, and hormonal regulation. Her recent publications reveal a strong emphasis on translating microbiome findings into clinical applications, particularly regarding bacterial modulators of disease processes.

Current major projects include:

• EU690: CoRe Defense (2025-2030) - Fortifying gut microbiota colonization resistance against intestinal infections
• OZR4397 (2025-2029) - High throughput screening for narrow-range anti-Campylobacter compounds

Her research has generated significant attention, with publications appearing in high-impact journals including Endocrinology, Gut Microbes, Diabetes, and Microbiome, and receiving citations across multiple platforms.